Revolution Medicines, Inc. Increase (Decrease) in Accounts Receivable
Revolution Medicines, Inc. (RVMD) reported Increase (Decrease) in Accounts Receivable of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-02-25
- Revolution Medicines, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $0.00.
- Revolution Medicines, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $0.00.
- Revolution Medicines, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was $0.00.
- Revolution Medicines, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was $0.00.
- Revolution Medicines, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $0.00.
- Revolution Medicines, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$1.25M.
- Revolution Medicines, Inc. increase (decrease) in accounts receivable for fiscal 2023 was -$3.42M.
- Revolution Medicines, Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$1.26M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | -$1.25M 10-K · filed 2026-02-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | -$1.25M 10-Q · filed 2025-11-05 | -$309.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$1.25M 10-Q · filed 2025-08-06 | -$309.00K derived: sum of 3 quarters · filed 2026-02-25 | -$2.51M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$1.25M 10-Q · filed 2025-05-07 | -$309.00K derived: sum of 2 quarters · filed 2026-02-25 | -$2.51M derived: sum of 3 quarters · filed 2026-02-25 | -$4.00M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $945.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.26M derived: sum of 2 quarters · filed 2026-02-25 | -$2.74M derived: sum of 3 quarters · filed 2026-02-25 | -$3.42M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$3.69M derived: sum of 2 quarters · filed 2024-11-06 | -$4.36M 10-Q · filed 2024-11-06 | -$4.63M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | -$1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$2.16M 10-Q · filed 2024-08-07 | -$2.43M derived: sum of 3 quarters · filed 2025-02-26 | -$3.11M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | -$678.00K 10-Q · filed 2024-05-08 | -$945.00K derived: sum of 2 quarters · filed 2025-02-26 | -$1.63M derived: sum of 3 quarters · filed 2025-02-26 | -$1.39M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$951.00K derived: sum of 2 quarters · filed 2025-02-26 | -$710.00K derived: sum of 3 quarters · filed 2025-02-26 | -$1.26M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$684.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$443.00K derived: sum of 2 quarters · filed 2023-11-06 | -$989.00K 10-Q · filed 2023-11-06 | -$2.47M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $241.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$305.00K 10-Q · filed 2023-08-08 | -$1.79M derived: sum of 3 quarters · filed 2024-02-26 | -$903.00K derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | -$546.00K 10-Q · filed 2023-05-08 | -$2.03M derived: sum of 2 quarters · filed 2024-02-26 | -$1.14M derived: sum of 3 quarters · filed 2024-02-26 | -$2.18M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$598.00K derived: sum of 2 quarters · filed 2024-02-26 | -$1.64M derived: sum of 3 quarters · filed 2024-02-26 | -$464.00K 10-K · filed 2024-02-26 |
| 2021-09-30 | $885.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$152.00K derived: sum of 2 quarters · filed 2022-11-07 | $1.02M 10-Q · filed 2022-11-07 | -$1.89M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $134.00K 10-Q · filed 2022-08-09 | -$2.77M derived: sum of 3 quarters · filed 2023-02-27 | -$804.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $1.17M 10-Q · filed 2022-05-09 | -$1.74M derived: sum of 2 quarters · filed 2023-02-27 | $233.00K derived: sum of 3 quarters · filed 2023-02-27 | -$886.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$938.00K derived: sum of 2 quarters · filed 2023-02-27 | -$2.06M derived: sum of 3 quarters · filed 2023-02-27 | -$2.34M 10-K · filed 2023-02-27 |
| 2020-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $849.00K derived: sum of 2 quarters · filed 2021-11-10 | $562.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$1.41M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | -$287.00K 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $1.43M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |